S-adenosyl-L-methionine (SAMe): Clinical Trials

2 trials of S-adenosyl-L-methionine (SAMe), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Not yet recruiting 1

Follow S-adenosyl-L-methionine (SAMe): new trials by email Literature Review of S-adenosyl-L-methionine (SAMe) trials Research Report on S-adenosyl-L-methionine (SAMe)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis
S-adenosyl-L-methionine (SAMe), Placabo - Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Phase 2Not yet recruitingCedars-Sinai Medical Center942026-04-152026-03-31
S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)
S-Adenosyl-L-methionine (SAMe), Placebo - Primary Sclerosing Cholangitis (PSC)
Not applicableCompletedMedical University of Warsaw602023-09-012026-08-25

Conditions studied

Cholangitis, Sclerosing (1)

Sponsors

Cedars-Sinai Medical Center (1)  ·  Medical University of Warsaw (1)

Countries

Poland (1)

Top investigators

Piotr Milkiewicz, MD, PhD (1)